Successful Treatment with Dupilumab of Acquired Reactive Perforating Collagenosis with End-stage Renal Disease

Authors

  • Shanglin Jin Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
  • Xiaoyao Fan Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
  • Jin Chen Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
  • Ying Ma Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China

DOI:

https://doi.org/10.2340/actadv.v105.43108

Keywords:

Acquired reactive perforating collagenosis, pruritus, dupilumab

Downloads

Download data is not yet available.

References

Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis: report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 575–580.

https://doi.org/10.1016/S0190-9622(94)70065-6 DOI: https://doi.org/10.1016/S0190-9622(94)70065-6

Liu B, Wu Y, Wu X, Zhong X, Xue R, Zhang Z. Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation. Front Immunol 2023; 14: 1240262.

https://doi.org/10.3389/fimmu.2023.1240262 DOI: https://doi.org/10.3389/fimmu.2023.1240262

Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, et al. Chronic pruritus: a review. JAMA 2024; 331: 2114–2124.

https://doi.org/10.1001/jama.2024.4899 DOI: https://doi.org/10.1001/jama.2024.4899

Ying Y, Shuang C, Zhen-Ying Z. Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD. Immun Inflamm Dis 2022; 10: e574.

https://doi.org/10.1002/iid3.574 DOI: https://doi.org/10.1002/iid3.574

Downloads

Published

2025-03-18

How to Cite

Jin, S., Fan, X., Chen, J., & Ma, Y. (2025). Successful Treatment with Dupilumab of Acquired Reactive Perforating Collagenosis with End-stage Renal Disease. Acta Dermato-Venereologica, 105, adv43108. https://doi.org/10.2340/actadv.v105.43108

Issue

Vol. 105 (2025)

Section

Research letter

Categories

License

Copyright (c) 2025 Shanglin Jin, Xiaoyao Fan, Jin Chen, Ying Ma

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC